Detalhe da pesquisa
1.
Better long-term speech outcomes in stroke survivors who received early clinical speech and language therapy: What's driving recovery?
Neuropsychol Rehabil
; 32(9): 2319-2341, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34210238
2.
Right hemisphere structural adaptation and changing language skills years after left hemisphere stroke.
Brain
; 140(6): 1718-1728, 2017 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28444235
3.
The PLORAS Database: A data repository for Predicting Language Outcome and Recovery After Stroke.
Neuroimage
; 124(Pt B): 1208-1212, 2016 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25882753
4.
Gradual lesion expansion and brain shrinkage years after stroke.
Stroke
; 45(3): 877-9, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24425126
5.
Treatment of relapsed/refractory germ cell tumours: an equipoise between conventional and high dose therapy.
Curr Treat Options Oncol
; 13(2): 201-11, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22623055
6.
The effect of sunitinib on immune subsets in metastatic clear cell renal cancer.
Urol Int
; 86(1): 53-9, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-20975250
7.
Phase 1, pharmacogenomic, dose-expansion study of pegargiminase plus pemetrexed and cisplatin in patients with ASS1-deficient non-squamous non-small cell lung cancer.
Cancer Med
; 10(19): 6642-6652, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34382365
8.
Phase II Randomized Preoperative Window-of-Opportunity Study of the PI3K Inhibitor Pictilisib Plus Anastrozole Compared With Anastrozole Alone in Patients With Estrogen Receptor-Positive Breast Cancer.
J Clin Oncol
; 34(17): 1987-94, 2016 06 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-26976426
9.
The application of the National Institute of Clinical Excellence guidelines for treatment of metastatic renal cell carcinoma in the United Kingdom: friend or foe?
BJU Int
; 106(4): 453-7, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20576026
10.
On-line monitoring of continuous flow chemical synthesis using a portable, small footprint mass spectrometer.
J Am Soc Mass Spectrom
; 25(10): 1794-802, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25106707
11.
A phase Ib study investigating the combination of everolimus and dovitinib in vascular endothelial growth factor refractory clear cell renal cancer.
Eur J Cancer
; 50(12): 2057-64, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24908540
12.
The management of low-stage non-seminomatous germ cell tumors.
Oncol Rev
; 6(2): e19, 2012 Oct 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-25992217
13.
Sequential FDG-PET/CT as a biomarker of response to Sunitinib in metastatic clear cell renal cancer.
Clin Cancer Res
; 17(18): 6021-8, 2011 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21742806
14.
The hazards of cross comparing the drug toxicity results from different trials in metastatic renal cancer: in response to a letter from Dr. Catalá-López.
Eur J Cancer
; 49(4): 986-7, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23138000
15.
New prognostic models in metastatic renal cancer.
Transl Androl Urol
; 1(3): 144-5, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26816702